Authors:
Brijker, F
Magee, CC
Tervaert, JWC
O'Neill, S
Walshe, JJ
Citation: F. Brijker et al., Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies, CLIN NEPHR, 52(6), 1999, pp. 344-351
Authors:
Ikeda, K
Ida, O
Kimoto, K
Takatorige, T
Nakanishi, N
Tatara, K
Citation: K. Ikeda et al., Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157 : H7 infection, CLIN NEPHR, 52(6), 1999, pp. 357-362
Authors:
Harmoinen, APT
Kouri, TT
Wirta, OR
Lehtimaki, TJ
Rantalaiho, V
Turjanmaa, VMH
Pasternack, AI
Citation: Apt. Harmoinen et al., Evaluation of plasma cystatin C as a marker for glomerular filtration ratein patients with type 2 diabetes, CLIN NEPHR, 52(6), 1999, pp. 363-370
Authors:
Tucker, B
Fabbian, F
Giles, M
Johnston, A
Baker, LRI
Citation: B. Tucker et al., Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure, CLIN NEPHR, 52(6), 1999, pp. 377-382
Authors:
van Ginneken, EEM
Assmann, KJM
Koolen, MI
Jansen, JLJ
Wetzels, JFM
Citation: Eem. Van Ginneken et al., Fibrillary-immunotactoid glomerulopathy with renal deposits of IgA lambda:a rare cause of glomerulonephritis, CLIN NEPHR, 52(6), 1999, pp. 383-389
Citation: Jy. Wang et al., Pericardial tamponade in chronic dialysis patients: transesophageal echocardiogram during pericardial drainage, CLIN NEPHR, 52(6), 1999, pp. 390-392
Citation: L. Grcevska et M. Polenakovic, A long-term follow-up (21 years) of a patient with class III lupus nephritis - complete remission of the renal involvement and death because of CNS involvement, CLIN NEPHR, 52(6), 1999, pp. 394-397
Citation: Hh. Malluche et Mc. Monier-faugere, Understanding and managing hyperphosphatemia in patients with chronic renal disease, CLIN NEPHR, 52(5), 1999, pp. 267-277
Authors:
Kondo, S
Yoshizawa, N
Kusumi, Y
Takeuchi, A
Torikata, C
Citation: S. Kondo et al., Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF), CLIN NEPHR, 52(5), 1999, pp. 278-284
Authors:
Scholl, U
Wastl, U
Risler, T
Braun, N
Grabensee, B
Heering, P
Schollmeyer, P
Zauner, I
Stein, G
Funfstuck, R
Keller, F
Citation: U. Scholl et al., The "point of no return" and the rate of progression in the natural history of IgA nephritis, CLIN NEPHR, 52(5), 1999, pp. 285-292
Authors:
Yorioka, N
Taniguchi, Y
Amimoto, D
Ogata, S
Sakikubo, E
Yamakido, M
Naito, T
Shimamoto, F
Citation: N. Yorioka et al., Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis, CLIN NEPHR, 52(5), 1999, pp. 293-296
Citation: C. Mrowka et al., Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?, CLIN NEPHR, 52(5), 1999, pp. 312-321